[Form 4] Cytokinetics Inc. Insider Trading Activity

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

4

07/16/2025 - 05:45 PM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Cytokinetics Inc

NASDAQ:CYTK

CYTK Rankings

#1244 Ranked by Market Cap

N/A Ranked by Dividends

CYTK Latest News

Aug 31, 2025

Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025

Aug 30, 2025

Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine

Aug 27, 2025

Cytokinetics to Participate in September Investor Conferences

Aug 25, 2025

Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025

Aug 20, 2025

Cytokinetics Names Jim Daly to Board of Directors

CYTK Latest SEC Filings

Sep 2, 2025

[8-K] Cytokinetics Inc. Reports Material Event

Sep 2, 2025

[Form 4] Cytokinetics Inc. Insider Trading Activity

Sep 2, 2025

[144] Cytokinetics Inc. SEC Filing

Sep 2, 2025

[Form 4] Cytokinetics Inc. Insider Trading Activity

Sep 2, 2025

[Form 4] Cytokinetics Inc. Insider Trading Activity

CYTK Stock Data

Market Cap 5.95B

Float 117.20M

Insiders Ownership 0.7%

Institutions Ownership 117.94%

Short Percent 12.98%

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City SOUTH SAN FRANCISCO